Dementia with Lewy bodies: Improving diagnostic criteria

Neurology

Volumn 60, Issue 10, 2003, Pages 1571-1572

  Lippa, Carol F ^a   McKeith, Ian ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; TAU PROTEIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL FEATURE; COGNITIVE DEFECT; DEMENTIA; DIAGNOSTIC ACCURACY; DIFFUSE LEWY BODY DISEASE; DOPAMINE UPTAKE; EDITORIAL; HUMAN; LEWY BODY; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL;

EID: 0037799535     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000066054.20031.b0     Document Type: Editorial

References (11)

1. McKhann G, Drachman DA, Folstein MF, Kawabata M, Price DL, Stanton J. Clinical diagnosis of Alzheimer disease: report of the NINCDS-ADRDA Work Group under the auspices of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
2. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 1996;47:1113-1124.
3. Merdes AR, Hansen LA, Jeste DV, et al. Influence of Alzheimer pathology on clinical diagnostic criteria in dementia with Lewy bodies. Neurology 2003;60:1586-1590.
4. McKeith IG, Ballard C, Perry RH, et al. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000;54:1050-1058.
5. McKeith IG, Fairbairn AF, Bothwell RA, et al. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994;44:872-877.
6. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41:479-486.
7. Braak H, Braak E. Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging 1997;18:S85-S88.
8. Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O'Brien JT. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology 1999;52:1153-1158.
9. Walker Z, Costa DC, Ince P, McKeith IG, Katona CL. In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies. Lancet 1999;354:646-647.
10. Lippa CF, Popescu A, Lee VM-Y, Trojanowski JQ. Lewy bodies in neurodegenerative disease: does tau phosphorylation predispose to secondary inclusion formation? Ann Neurol 2002;52:A309.
11. Lippa CF, Schmidt ML, Lee VM, Trojanowski JQ. Antibodies to alphasynuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. Ann Neurol 1999;45:353-357.